Tuberous Sclerosis, Type II Diabetes Mellitus and the PI3K/AKT/mTOR Signaling Pathways-Case Report and Literature Review

被引:7
|
作者
Jurca, Claudia Maria [1 ,2 ]
Kozma, Kinga [1 ,2 ]
Petchesi, Codruta Diana [1 ,2 ]
Zaha, Dana Carmen [1 ]
Magyar, Ioan [1 ]
Munteanu, Mihai [3 ]
Faur, Lucian [3 ]
Jurca, Aurora [4 ]
Bembea, Dan [5 ]
Severin, Emilia [6 ]
Jurca, Alexandru Daniel [1 ]
机构
[1] Univ Oradea, Fac Med & Pharm, Dept Preclin Disciplines, Oradea 410081, Romania
[2] Cty Emergency Clin Hosp Oradea, Reg Ctr Med Genet Bihor, Oradea 410469, Romania
[3] Univ Oradea, Fac Med & Pharm, Dept Med Disciplines, Oradea 410081, Romania
[4] Univ Oradea, Fac Med & Pharm, Oradea 410081, Romania
[5] Univ Med & Pharm Iuliu Hatieganu, Fac Med, Cluj Napoca 400012, Romania
[6] Univ Med & Pharm Carol Davila, Dept Genet, Bucharest 020021, Romania
关键词
tuberous sclerosis; hamartomas; TSC1; TSC2; epilepsy; type 2 diabetes mellitus; Metformin; MAMMALIAN TARGET; GLUCOSE-UPTAKE; COMPLEX; TSC1; MTOR; CELL; KINASE; EXPRESSION; MANAGEMENT; METFORMIN;
D O I
10.3390/genes14020433
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Tuberous sclerosis complex (TSC) is a rare autosomal dominant neurocutaneous syndrome. It is manifested mainly in cutaneous lesions, epilepsy and the emergence of hamartomas in several tissues and organs. The disease sets in due to mutations in two tumor suppressor genes: TSC1 and TSC2. The authors present the case of a 33-year-old female patient registered with the Bihor County Regional Center of Medical Genetics (RCMG) since 2021 with a TSC diagnosis. She was diagnosed with epilepsy at eight months old. At 18 years old she was diagnosed with tuberous sclerosis and was referred to the neurology department. Since 2013 she has been registered with the department for diabetes and nutritional diseases with a type 2 diabetes mellitus (T2DM) diagnosis. The clinical examination revealed: growth delay, obesity, facial angiofibromas, sebaceous adenomas, depigmented macules, papillomatous tumorlets in the thorax (bilateral) and neck, periungual fibroma in both lower limbs, frequent convulsive seizures; on a biological level, high glycemia and glycated hemoglobin levels. Brain MRI displayed a distinctive TS aspect with five bilateral hamartomatous subependymal nodules associating cortical/subcortical tubers with the frontal, temporal and occipital distribution. Molecular diagnosis showed a pathogenic variant in the TSC1 gene, exon 13, c.1270A>T (p. Arg424*). Current treatment targets diabetes (Metformin, Gliclazide and the GLP-1 analog semaglutide) and epilepsy (Carbamazepine and Clonazepam). This case report presents a rare association between type 2 diabetes mellitus and Tuberous Sclerosis Complex. We suggest that the diabetes medication Metformin may have positive effects on both the progression of the tumor associated with TSC and the seizures specific to TSC and we assume that the association of TSC and T2DM in the presented cases is accidental, as there are no similar cases reported in the literature.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] TDRG1 functions in testicular seminoma are dependent on the PI3K/Akt/mTOR signaling pathway
    Wang, Yong
    Gan, Yu
    Tan, Zhengyu
    Zhou, Jun
    Kitazawa, Riko
    Jiang, Xianzhen
    Tang, Yuxin
    Yang, Jianfu
    ONCOTARGETS AND THERAPY, 2016, 9 : 409 - 420
  • [32] Erythropoietin promoted intraplaque angiogenesis by PI3K/AKT/mTOR signaling pathway in atherosclerosis
    Wang, Ying
    Li, Yongjun
    Liu, Dongxia
    TISSUE & CELL, 2023, 82
  • [33] The exosome-mediated PI3k/Akt/mTOR signaling pathway in cervical cancer
    Zhang, Wenyuan
    Zhou, Qing
    Wei, Yunhai
    Da, Miao
    Zhang, Chun
    Zhong, Jing
    Liu, Jin
    Shen, Junjun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2019, 12 (07): : 2474 - 2484
  • [34] Flavonoids and PI3K/Akt/mTOR signaling cascade: A potential crosstalk in anticancer treatment
    ul Islam, Badar
    Suhail, Mohd
    Khan, Mohd Shahnawaz
    Ahmad, Ajmal
    Zughaibi, Torki A.
    Husain, Fohad M.
    Rehman, Md Tabish
    Tabrez, Shams
    CURRENT MEDICINAL CHEMISTRY, 2021, 28 (39) : 8083 - 8097
  • [35] Allicin attenuates pathological cardiac hypertrophy by inhibiting autophagy via activation of PI3K/Akt/mTOR and MAPK/ERK/mTOR signaling pathways
    Ba Lina
    Gao Jingquan
    Chen Yunping
    Qi Hanping
    Dong Chonghui
    Pan Hao
    Zhang Qianhui
    Shi Pilong
    Song Chao
    Guan Xueying
    Cao Yonggang
    Sun Hongli
    PHYTOMEDICINE, 2019, 58
  • [36] Wortmannin Attenuates Seizure-Induced Hyperactive PI3K/Akt/mTOR Signaling, Impaired Memory, and Spine Dysmorphology in Rats
    Carter, Angela N.
    Born, Heather A.
    Levine, Amber T.
    Dao, An T.
    Zhao, Amanda J.
    Lee, Wai L.
    Anderson, Anne E.
    ENEURO, 2017, 4 (03)
  • [37] Gymnemic Acid Ameliorates Hyperglycemia through PI3K/AKT- and AMPK-Mediated Signaling Pathways in Type 2 Diabetes Mellitus Rats
    Li, Yumeng
    Liu, Yaping
    Liang, Junjie
    Wang, Tianxin
    Sun, Mingzhe
    Zhang, Zesheng
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2019, 67 (47) : 13051 - 13060
  • [38] Target regulation of PI3K/Akt/mTOR pathway by cannabidiol in treatment of experimental multiple sclerosis
    Giacoppo, Sabrina
    Pollastro, Federica
    Grassi, Gianpaolo
    Bramanti, Placido
    Mazzon, Emanuela
    FITOTERAPIA, 2017, 116 : 77 - 84
  • [39] Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer
    Saini, Kamal S.
    Loi, Sherene
    de Azambuja, Evandro
    Metzger-Filho, Otto
    Saini, Monika Lamba
    Ignatiadis, Michail
    Dancey, Janet E.
    Piccart-Gebhart, Martine J.
    CANCER TREATMENT REVIEWS, 2013, 39 (08) : 935 - 946
  • [40] Suppressive effects of plumbagin on the growth of human bladder cancer cells via PI3K/AKT/mTOR signaling pathways and EMT
    Zhang, Renjie
    Wang, Zijian
    You, Wenjie
    Zhou, Fengfang
    Guo, Zicheng
    Qian, Kaiyu
    Xiao, Yu
    Wang, Xinghuan
    CANCER CELL INTERNATIONAL, 2020, 20 (01)